Brief: Revive Therapeutics Enters Into Research Collaboration Agreement With Pharmather
03/11/2021 12:25
Nov 3 (Reuters) - Pharmather Holdings Ltd PHRM.CD :
* REVIVE THERAPEUTICS ENTERS INTO RESEARCH COLLABORATION
AGREEMENT
WITH PHARMATHER FOR DEVELOPMENT OF PSILOCYBIN MICRONEEDLE PATCH
Source text for Eikon: ID:nGNX3CVRT0
Further company coverage: PHRM.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revive Therapeutics
See all newsBrief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Announces Closing Of Second Tranche Of Private Placement
Brief: Revive Therapeutics Nears Completion Of Key Nerve Agent Countermeasure Study With Canadian Department Of National Defence
Brief: Revive Therapeutics Provides Update On Research Study Evaluating Bucillamine For Nerve Agent Exposure